Latest news
Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development - AOL.comAOL.com · Mon, 10 Aug 2026 11:01:11 GMTRevolune and Propath UK Bring Service-Backed Multiplex immunofluorescence Workflows to Biopharma Customers - PR NewswirePR Newswire · Wed, 05 Aug 2026 07:00:00 GMTRevolune Announces Service Provider Program with CellCarta, Concept Life Sciences, and Propath UK - PR NewswirePR Newswire · Tue, 04 Aug 2026 12:00:00 GMT